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It has been known for at least 100 years that protein such individuals, the development of malnutrition paral-
restriction reduces symptoms in chronic renal failure lels the progression of uremia and anorexia, as dietary
(CRF) [1]. Because most of these symptoms are caused intake of calories and protein falls [23]. The appropriate
by accumulation of the products of protein metabolism, response to these developments, we believe, is the insti-
this is to be expected. The history of the use of protein- tution of a well-designed, low-protein diet, rather than
restricted diets in renal disease has been reviewed else- early dialysis.
where [2, 3]. There are also no data supporting the second assump-
In the last decade, two findings have cast doubt on tion, with the obvious exception of starting dialysis in
the wisdom of administering low-protein diets to CRF severely uremic patients. The third assumption is also
patients: First, a large body of evidence has documented unsupported by the literature: Protein nutrition of CRF
that hypoalbuminemia in dialysis patients is a major risk patients is usually maintained or improved by low-pro-
factor for mortality, whether present at the onset of tein or supplemented very low protein diets. Hence, a
dialysis or developed during dialysis [4–19]. Other indi- well-planned, low-protein diet not only maintains or im-
ces of nutritional status, such as urea nitrogen appear- proves nutritional state (including serum albumin levels)
ance and predialysis levels of creatinine and cholesterol, in predialysis patients, but by reducing symptoms, it also
are also correlated with mortality [4–19]. Second, the delays the need for dialysis. Moreover, substantial evi-
hypothesis that protein restriction slows the progression dence suggests that it may also slow the rate of progres-
of CRF (another rationale for its use) has not been un- sion of renal insufficiency.
equivocally confirmed (discussed later here). As a result The benefits of a nutritional regimen include the fol-
of these findings, some workers have questioned the lowing: (a) reduction in (or delayed onset of) symptoms
wisdom of restricting protein intake [20–22]. Further- and signs of uremia; (b) forestalling complications by
more, they have suggested that if spontaneous protein lowering the accumulation of waste products at any given
intake falls below 0.8 g/kg/day, patients are at increased level of glomerular filtration rate (GFR); and (c) perhaps
risk of malnutrition, and the appropriate response is to slowing the rate of decline of GFR. Objections that have
start dialysis unless protein intake can be increased. The been raised include cost, poor compliance, and perhaps
assumptions underlying these recommendations are that: the increased risk of malnutrition. In this article, we
(a) protein nutrition will improve in predialysis patients review the evidence supporting each of these benefits,
if protein intake increases; (b) dialysis improves dietary as well as the evidence for each of these objections.
intake and nutritional status; and (c) low protein intake
causes malnutrition in predialysis patients.
BENEFITSAs far as we can determine, there is no evidence sup-
porting the first assumption in patients previously receiv- Symptoms and signs
ing a well-designed, low-protein diet. However, most pre- It has been repeatedly demonstrated that protein-
dialysis patients receive little or no dietary instruction and, restricted diets reduce uremic signs and symptoms [24–
therefore, are not on well-designed, low-protein diets. In 43]. Almost all of the manifestations of the uremic state
are ameliorated, with the exception of anemia; even pe-
ripheral neuropathy [37], insulin resistance [44, 45], redKey words: chronic renal failure, diet, protein metabolism, renal dis-
ease and diet, dialysis. cell lipid peroxidation [46], and osteodystrophy [47, 48]
can improve. Improvement in osteodystrophy may beReceived for publication October 13, 1997
related to the reduced phosphorus intake associated withand in revised form June 23, 1998
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fits ensue with either low-protein diets or very low pro- ment for chronic dialysis therapy (see note added in
proof).tein diets supplemented by essential amino acids or keto-
acids. Although many improvements have been observed
Progressionfollowing the introduction of a very low protein diet supple-
The effect of protein restriction on the rate of loss ofmented by ketoanalogues [43–58], claims for unique bio-
renal function remains uncertain [65]. The MDRD Studychemical effects of ketoacids have not been proven. In
was the most extensive trial devoted to this question,a small number of studies [59–63], the biochemical effects
but it nevertheless yielded an ambiguous result [66, 67].of essential amino acid supplements have been compared
This uncertainty has led some workers to conclude thatwith the effects of ketoacid supplements to the same
protein restriction is not advisable, but as noted in thevery low protein diet. Only minor differences in serum
preceding section, protein restriction reduces symptomsand urine biochemical parameters have been found be-
and signs and also forestalls dialysis even if it has notween these two regimens, and no difference in nitrogen
effect on progression.balance or protein turnover has been found [63]. Because
Although the MDRD Study was a sophisticated multi-ketoacids are not currently available in United States,
center trial, certain aspects of the design made the resultsthis discussion focuses principally on the use of two regi-
difficult to interpret. These aspects have been discussedmens: a low-protein diet (0.6 g/kg) and an essential amino
in detail [65] and are only briefly considered here. Thereacid-supplemented, very low protein diet (0.3 g/kg).
were positive trends emerging when the MDRD Study
ended after an average follow-up of only 2.2 years. ThisForestalling dialysis
is a short trial compared with the typical course of renalThe production of urea and other nitrogenous waste
failure. For example, in the Diabetes Control and Com-products depends on protein intake [64]. Because symp-
plications Trial [69], the effects of intensive blood glucosetoms are correlated with (but not necessarily caused by)
control on the development of long-term complicationsthe level of serum urea nitrogen [27, 29, 31], symptoms at
were examined in patients with insulin-dependent diabe-any given level of renal function are reduced by protein
tes mellitus; if the patients in this trial had been followedrestriction. Unless nitrogen balance becomes negative,
for only 2.2 years, the study would have been negative.the decrease in urea nitrogen output must be nearly equal
Also, in the MDRD Study, a high proportion of patientsto the decrease in nitrogen intake, as other components
with polycystic kidney disease, as well as a number ofof nitrogen excretion are scarcely affected by protein
patients in whom renal insufficiency was not progressing,restriction [42, 64]. Thus, serum urea nitrogen concentra-
was enrolled; their inclusion may have affected the out-
tion falls proportionately more than N intake. Mainte-
come. In more advanced renal insufficiency, a control
nance dialysis therapy is often initiated when uremic group receiving a normal protein intake could not in-
symptoms begin. Consequently, the need to initiate dial- cluded because this regimen was thought to be harmful.
ysis may be deferred by low-protein diets, even if there In patients with insulin-dependent diabetic nephropa-
is no change in the rate of loss of renal function. The thy (who were excluded from the MDRD Study), protein
number of months that dialysis is postponed will vary with restriction was shown to slow progression significantly
the rate of progression. If GFR is declining rapidly, for in one well-controlled study [70]. Two meta-analyses of
example, 1 ml/min/month, protein restriction will only studies of the effects of protein restriction on progression
delay dialysis by a few months (assuming that it has no [71, 72] concluded that low-protein diets slow progres-
effect on progression), but if progression continues at a sion of both diabetic and nondiabetic renal disease. How-
more common rate of 0.3 ml/min/month (3.6 ml/min/ ever, the validity of meta-analyses has recently been
year) [65, 66], protein restriction may postpone dialysis questioned [73].
by a year or more. For example, in the Modification of Whether ketoacid supplements exert an additional ef-
Diet in Renal Disease (MDRD) Study, patients with fect to slow progression beyond the effect of protein re-
lower protein intakes had significantly lower GFR and striction remains uncertain. In a randomized cross-over
higher serum creatinine concentrations (that is, more study, using the ketoacid-based formulation designated
advanced renal insufficiency) just prior to dialysis than “EE,” Walser et al found significantly slower progression
those consuming a higher protein intake [67]. It was (by 45%, P 5 0.024) in 16 patients in comparison with
concluded that dietary protein restriction prolonged the the same diet supplemented by essential amino acids
interval to renal death in part by delaying the occurrence [60]. In the Feasibility Phase of the MDRD Study, formu-
of uremic symptoms. We have found that dialysis can lation “EE” plus a 0.3 g/kg protein diet was given to
safely be deferred by dietary therapy for a median of patients with advanced renal failure. These patients pro-
one year after patients reach the GFR level (10 ml/min gressed significantly more slowly than patients given an
in nondiabetics and 15 ml/min in diabetics), which is essential amino acid supplement to the same diet [74].
In the full-scale MDRD Study, a different ketoacid for-defined by Medicare [68] as the criterion for reimburse-
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mulation was employed [66, 74]. Progression was again imperfect compliance, it represents a substantial reduc-
tion in protein intake. Although these studies employedslower in those who received the supplement, but the
effect was only marginally significant (P , 0.07) despite dietary counseling and monitoring, these techniques are
not difficult [34, 60, 64]. This is relevant because therethe larger number of patients studied [66]. On the other
hand, in a retrospective analysis of these data in patients is evidence for retardation of progression of renal failure
even when patients are not closely compliant with thewith advanced renal failure, the actual (as opposed to
prescribed) protein intake was associated with slowed protein prescription [60, 67]. In the MDRD Study [78],
subjects with the greatest level of satisfaction, in everyprogression [67]; prescription of the ketoacid mixture
used in this trial conferred no additional benefit (compli- diet group, were those whose adherence to the diet pre-
scription was the best, as would be expected.ance with this prescription was not taken into account).
Further studies of these questions are needed. It must be emphasized that a low-protein diet repre-
sents a major change in lifestyle. A skilled dietitian can
design an attractive diet that is restricted in protein con-
OBJECTIONS
tent. Support of family members and the individual who
Cost prepares the food is critical. Thus, this approach is not
feasible for all subjects. However, chronic dialysis is notOne objection to the use of low-protein regimens is
their expense. High-protein foods, however, are the most without its problems: The burdens of dialysis treatments
three times per week and dietary as well as fluid restric-costly items on most shopping lists, and limiting them
leads to substantial savings. Special low-protein foods tion are daunting. Most patients require many months to
adjust to life on dialysis. Annual mortality of end-stageare a useful (although not essential) adjunct to such
diets (especially very low protein diets) and are more renal disease patients on dialysis is 24% [80]. Of course,
mortality in end-stage renal disease patients who neverexpensive. However, low-protein bread, made at home
by hand or in a bread-making machine, costs little more receive dialysis is eventually 100%, but the mortality of
patients whose renal failure is sufficiently severe to qual-than that purchased in a grocery store. Essential amino
acid tablets, at a dose of 10 g/day, cost z$4 per day (such ify for reimbursement by Medicare but are treated con-
servatively until dialysis becomes unavoidable is far lower:as Aminesst, Nestle´ Homelink), which is generally less
than the foods they replace. The major cost of a low- 2.5% per annum in one small series of 67 patients with
end-stage renal failure (see note added in proof) andprotein regimen is the services of a skilled dietitian. The
number of times individual patients must be seen after 2.4% per annum in 128 MDRD patients with relatively
advanced renal failure [66].the first visit with the dietitian varies greatly; some indi-
viduals require frequent counseling, whereas one or two
Protein malnutritionvisits suffice for others. In the MDRD Study, the time
requirement for counseling by a dietitian was consider- Patients on dialysis often consume less than optimal
diets and are frequently malnourished [81, 82]. Evenable, owing to the research aspects of the study [75]. The
issue of the reimbursement of dietitian services is beyond well-dialyzed patients may exhibit hypoalbuminemia
[83]. The consumption of less than 1 g/kg/day of proteinthe scope of this review, but needs to be addressed.
Thus, low-protein regimens do not cost more than may contribute to the nutritional problems of dialysis
patients. However, in predialysis patients, the efficacyordinary food for most patients, except for the services
of the dietitian, the requirement for which varies widely of low-protein diets (0.6 g/kg/day) or supplemented very
low protein diets (0.3 g/kg/day) in maintaining nutritionbetween patients. More important, the cost of predialysis
care, including physician and dietitian fees and labora- is well documented [25–41, 56, 57, 59, 60, 66, 67, 77, 79,
84, 85]. On balance, the evidence supporting the safety oftory expenses, is substantially less than the cost of dialysis
(estimated to average $61,640 per year in 1994 to 1995) low-protein diets is of moderate-to-good quality clinical
science, performed in a variety of clinical situations in[76]; hence, savings attributable to any deferral of dialysis
will outweigh the increased predialysis costs. different geographic settings.
There are several reasons why low-protein diets do
Compliance not induce malnutrition in patients with CRF. First, these
diets provide an adequate intake of energy and otherAnother objection is that compliance is difficult to ob-
tain. It is certainly true that some patients refuse the diet, essential nutrients. Second, by providing a greater pro-
portion of high biological value protein (in the 0.6 g/kgand others fail to comply. However, there are many re-
ports in which measured protein intake averages 25 to protein diet) or the essential amino acids as such (in
the supplemented very low protein diet), these regimens50% above prescribed protein intake, that is, approxi-
mately 0.7 g/kg on a prescribed intake of 0.55 g/kg or contain sufficient amino acids to achieve neutral nitrogen
balance. Third, predialysis patients with CRF who do0.40 g/kg on a prescribed intake of 0.28 g/kg plus a supple-
ment [43, 59, 60, 66, 70, 77–79]. Although this is an not have complicating illnesses (for example, metabolic
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acidosis or glucocorticoid therapy) can activate the same protein diet is that of Lucas et al [50], who prescribed a
diet containing only 0.2 g/kg/day of protein. They foundadaptive responses to a low-protein diet as normal adults
[79, 86, 87]. For these reasons and because proteinuria that serum albumin and transferrin levels remained con-
stant, but body weight and arm muscle circumferenceserves as an additional stimulus to protein-conserving
mechanisms [86], the minimal protein requirement of decreased. By contrast, we are not aware of any studies
reporting that serum albumin levels can be augmentedpredialysis patients is no greater than in normal subjects
[31, 34, 40, 79, 85–87]. In contrast, predialysis patients by increasing protein intake. Encouraging patients to eat
more protein could increase uremic symptoms and worsenwho eat too much protein can develop uremic symptoms,
including nausea, vomiting, acidosis, and edema (from nutritional status. Only under special conditions have rec-
ommendations to increase protein intake been advocated.excess dietary sodium). These complications will reduce
the intake of all nutrients and will lead to a decline in For example, the recently promulgated “DOQI” guide-
lines [92] state, “With urinary protein losses in the ne-nutritional status.
Nutritional measurements during both phases of the phrotic range . . . a nPNA of 0.9 g/kg/day or more may
be necessary to maintain nitrogen balance. ComorbidMDRD Study have confirmed the adequacy of protein-
restricted diets [77, 78, 88]. In the Feasibility Phase [88], causes of anorexia such as gastroparesis, infection, acido-
sis, and depression should be identified and treated.which employed an essential amino acid supplement as
well as a ketoacid supplement, serum albumin and trans- However, if these measures fail to restore nPNA to 0.8
g/kg/day or higher, the Work Group recommends thatferrin levels declined in a few patients but did not become
subnormal. No patients became malnourished, even dialysis be initiated.” On the contrary, we recommend
that normalized protein N appearance (nPNA) be re-though mean energy intake fell below recommended
values. In the full-scale MDRD trial [77], patients as- duced, as part of a carefully designed diet plan, before
dialysis is initiated.signed to the low-protein or very low protein diets lost
approximately 2 kg and showed a decrease in other an- In nephrotic patients, high-protein diets were recom-
mended until recently to compensate for urinary proteinthropometric parameters during the first four months
only, probably because of reduced energy intake. Serum losses. This recommendation was questioned when Kay-
sen et al reported that restriction of dietary protein toalbumin levels rose but transferrin levels fell (although
not to subnormal values) in patients assigned to low- 0.8 g/kg led to a decrease in urinary protein loss and an
increase of 0.21 g/dl in serum albumin concentration [93].protein or very low protein diets. In summary, “Biochem-
ical and anthropometric indices of nutritional status dur- These results have been repeatedly confirmed [94]. For
example, when five nephrotic patients with 3 to 14 g/daying follow-up were generally well within normal limits
in all four diet groups” [77]. A progressive decline in of proteinuria were fed 0.8 g/kg of dietary protein (plus
1 g of dietary protein per gram of proteinuria), nitrogencreatinine excretion was observed in the low-protein
groups and was probably related to reduced meat intake balance was neutral or positive [86]. When 16 nephrotic
patients were prescribed a very low protein diet (0.3 g/kg)and/or to increasing degradation of creatinine [89]. Loss
of skeletal muscle mass could not have contributed in a supplemented by essential amino acids (or, in a few, keto-
acids), serum albumin increased and serum cholesterolmajor way to the reduction of urinary creatinine excre-
tion because arm muscle area remained the same or and proteinuria decreased [94]. The small number of pa-
tients makes it impossible to generalize from these obser-decreased only slightly. Importantly, the low-protein reg-
imens were not associated with higher rates of death, vations, but the dictum that protein should not be severely
restricted in nephrotic subjects needs reconsideration.hospitalization, or any signs of malnutrition.
We reported that patients treated for 6 to 72 months In addition to reducing the accumulation of waste ni-
trogen, dietary protein restriction also reduces phospho-with supplemented very low protein diets rarely exhibit
hypoalbuminemia even at the start of renal replacement rus intake and hydrogen ion generation. In fact, the only
source of acid in a subject in nitrogen balance is dietarytherapy, in contrast to a 25 to 50% incidence of hypoal-
buminemia at the start of chronic dialysis nationwide protein. The consequences, in terms of biochemical ab-
normalities, of omitting dietary therapy are well demon-[90]. Furthermore, survival during the first two years of
dialysis was not adversely affected by protein restriction. strated by a survey of 911 patients followed for up to
seven years, apparently with little or no dietary proteinOn the contrary, it was substantially better than survival
rates reported nationwide, after adjusting for age, race, restriction [95]. In patients with serum creatinine of more
than 5 mg/dl, acidosis was common (serum CO2 wasgender, and diagnosis [91]. However, it is important to
note that these comparisons lack statistical validity be- below 15 mm in one third of these patients), serum phos-
phate was above 7 mg/dl in one third, and serum ureacause of the marked differences in prior follow-up, co-
morbidities, and diagnoses. N was above 120 mg/dl in one third. By contrast, very
few of the patients we have treated long-term [27, 29,The only study that we have identified in which malnu-
trition may have developed on a supplemented very low 34, 41, 59, 60, 79, 85] or followed until dialysis (see note
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added in proof) have exhibited such severe abnormali- regimens tend to prevent it, provided the diet contains
sufficient calories. Dialysis, by contrast, is associated withties.
Treatment of the predialysis patient also involves hypoalbuminemia in 25 to 50% of patients, as well as
other evidence for protein–calorie malnutrition, and en-other measures, such as control of hypertension, fluid
balance, calcium and phosphorus levels and bone demin- tails an annual mortality of approximately 24%. Although
it has yet to be firmly established that protein restrictioneralization, serum concentrations of bicarbonate, potas-
sium and uric acid, and anemia, and optimizing energy slows progression, reduction in signs and symptoms in
response to protein restriction has been repeatedly dem-intake. Correction of acidosis is particularly important
because acidosis promotes protein catabolism [96]. We onstrated; this effect alone will defer dialysis. We con-
clude that, with rare exceptions, patients with CRFattempt to keep serum CO2 $ 22 mEq/liter and prescribe
sodium bicarbonate in a large proportion of our patients should receive a trial of a protein-restricted regimen
before being started on dialysis.with advanced renal failure.
Several groups have recently reported that patient ed-
ucation by a multidisciplinary team can forestall dialysis,
NOTE ADDED IN PROOF
reduce the frequency of urgent initiation of dialysis, and
Walser M, Hill S: Can renal replacement be deferred by a supple-
reduce the number of hospital days in the first month of mented very low protein diet? J Am Soc Nephrol (in press)
dialysis [97–99]. Thus, there are many as yet unexplored
Reprint requests to Dr. Mackenzie Walser, Johns Hopkins Schoolopportunities for improving the quality of predialysis
of Medicine, 725 North Wolfe Street, Baltimore, Maryland 21205, USA.
care, not the least of which is a protein-restricted diet. E-mail: mwalser@bs.jhmi.edu
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